Bioenvision was acquired by Genzyme on October 23, 2007

Life Science Company

Out of 60 sectors in the Mergr database, life science ranked 11 in number of deals in 2007. The largest life science acquisition in 2007 was Organon BioSciences N.V. - which was acquired by Schering-Plough for $12.4B.

Join Mergr to view all 124 acquisitions of life science companies in 2007, including 24 acquisitions by private equity firms, and 100 by strategics.

Bioenvision, Inc.

345 Park Avenuem, 41st Floor,
New York City, New York 10154
United States,
(212) 750-6700
www.bioenvision.com

Biotechnology company focused on the development and commercialization of drugs to treat oncology and infectious diseases.


 Subscribe to unlock this and 159,618
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.1K Private Equity Firms
  • 148K M&A Transactions
  • 156K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.2K M&A Advisors
    (Investment Banks and Law Firms)
  • 47K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.